The investment will fund the Phase I/Ib study of CGX-926 for MC4R-deficient genetic obesity in healthy subjects and patients.

The financing was co-led by new investor Dimension and existing investor OrbiMed. Additional investors included Amplitude Ventures, FSTQ, Lumira, Investissement Quebec, BDC Capita ...

Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candidates in Neurology and Immunology Congruence to receive ...

Add Yahoo as a preferred source to see more of our stories on Google. The Mowbray brothers, entrepreneurs from New Zealand, are purportedly leveraging their toy-empire fortune to import 16 ...

Jujutsu Kaisen Modulo Chapter 21 is not too far away, and it’s gearing up. With the story racing toward another major turning point, Chapter 21 is set to turn up the intensity with new twists and ...

Gege Akutami and Yuji Iwasaki's sequel manga remembered to make a worthwhile story the connective tissue of its sorcery fighting series. Reading time 4 minutes When Jujutsu Kaisen‘s manga finally ...

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...

University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” PRINT technology it hopes will fuel a new wave of genetic medicine. Addition emerges from stealth with ...

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...